---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-010552"
form_type: "8-K"
ticker: null
cik: "0001411906"
company_name: "Ampio Pharmaceuticals, Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T12:44:42.790129+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ampio declares Series D Preferred stock dividend with super voting rights tied to reverse split

## Summary
- Board declared a dividend of 1/1000th share of Series D Preferred per common share; record date June 8, 2023.
- Each share of Series D Preferred has 1,000,000 votes, but only on reverse stock split proposals; vote mirrors common vote.
- Shares not present at reverse-split meeting automatically redeemed for $0.01 per 10 shares if certain conditions met.
- Bylaws amended to reduce quorum at stockholder meetings from majority to one-third of outstanding shares.

## SEC filing metadata
- accession: 0001558370-23-010552
- form_type: 8-K
- cik: 0001411906
- company_name: Ampio Pharmaceuticals, Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411906/000155837023010552/0001558370-23-010552-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411906/000155837023010552/ampe-20230524x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-010552
- JSON: https://secwatch.observer/filing/0001558370-23-010552.json
- Plain text: https://secwatch.observer/filing/0001558370-23-010552.txt

## Key facts
- Governance Changes
  Ampio Pharmaceuticals, Inc.: Amended bylaws to change quorum requirement at stockholder meetings from a majority to one-third of outstanding shares (effective 2023-05-24).
  - Change: bylaw amendment
  - Effective: 2023-05-24
  source text: On May 24, 2023, the board of directors the (“Board”) of Ampio Pharmaceuticals, Inc. (the “Company”), adopted and approved an amendment to the Company’s Amended and Restated Bylaws (the “ Bylaws Amendment ”) in order to change the proportion of shares present required to constitute a quorum at a meeting of stockholders, from a majority to one-third of the outstanding shares of stock entitled to vote.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411906/000155837023010552/0001558370-23-010552-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.